Eva Czirr

4.1k total citations
21 papers, 1.2k citations indexed

About

Eva Czirr is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Eva Czirr has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 7 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Eva Czirr's work include Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Eva Czirr is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Eva Czirr collaborates with scholars based in United States, Germany and Paraguay. Eva Czirr's co-authors include Tony Wyss‐Coray, Kira I. Mosher, Eliezer Masliah, Kurt M. Lucin, Sascha Weggen, Caitlin E. O’Brien, Gregor Bieri, Joseph Rogers, Brian Spencer and Diego Mastroeni and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Neuron.

In The Last Decade

Eva Czirr

20 papers receiving 1.2k citations

Peers

Eva Czirr
Nathaniel S. Woodling United States
Peter Sohn United States
Ilie‐Cosmin Stancu Belgium
Luka Kulic Switzerland
Michael A. Mastrangelo United States
Kristina Lindholm United States
Stacy A. Hussong United States
Mickaël Audrain France
Mary Lou Previti United States
Debbie Callaghan Canada
Nathaniel S. Woodling United States
Eva Czirr
Citations per year, relative to Eva Czirr Eva Czirr (= 1×) peers Nathaniel S. Woodling

Countries citing papers authored by Eva Czirr

Since Specialization
Citations

This map shows the geographic impact of Eva Czirr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Czirr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Czirr more than expected).

Fields of papers citing papers by Eva Czirr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Czirr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Czirr. The network helps show where Eva Czirr may publish in the future.

Co-authorship network of co-authors of Eva Czirr

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Czirr. A scholar is included among the top collaborators of Eva Czirr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Czirr. Eva Czirr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hall, John E., et al.. (2023). Noncanonical Activity of Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Improves Cognition and Synapse Density in Aging. eNeuro. 10(6). ENEURO.0031–23.2023. 7 indexed citations
3.
Rege, Sanket, Ninh V. Vu, R. Harish, et al.. (2023). Leukotriene A4 hydrolase inhibition improves age-related cognitive decline via modulation of synaptic function. Science Advances. 9(46). eadf8764–eadf8764. 4 indexed citations
4.
Rege, Sanket, David Le, Rebecca D. Ray, et al.. (2022). Molecular and histological correlates of cognitive decline across age in male C57BL/6J mice. Brain and Behavior. 12(9). e2736–e2736. 6 indexed citations
5.
Hannestad, Jonas, et al.. (2020). A Randomized, Double-Blind, Phase 2a Study to Evaluate the Tolerability, Feasibility, and Efficacy of AKST1210 in Patients on Hemodialysis with ESRD and Cognitive Impairment. Journal of the American Society of Nephrology. 31(10S). 377–378. 1 indexed citations
6.
Czirr, Eva, Nicholas A. Castello, Kira I. Mosher, et al.. (2017). Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. The Journal of Experimental Medicine. 214(4). 1081–1092. 101 indexed citations
7.
Middeldorp, Jinte, Benoit Lehallier, Saul Villeda, et al.. (2016). Preclinical Assessment of Young Blood Plasma for Alzheimer Disease. JAMA Neurology. 73(11). 1325–1325. 114 indexed citations
8.
Li, Wen‐Wu, Tian‐Zhi Guo, Xiaoyou Shi, et al.. (2014). Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. Pain. 155(11). 2377–2389. 75 indexed citations
9.
Lucin, Kurt M., Caitlin E. O’Brien, Gregor Bieri, et al.. (2013). Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s Disease. Neuron. 79(5). 873–886. 313 indexed citations
10.
Czirr, Eva & Tony Wyss‐Coray. (2012). The immunology of neurodegeneration. Journal of Clinical Investigation. 122(4). 1156–1163. 171 indexed citations
11.
12.
Jäger, Sebastian, Stefanie Leuchtenberger, Anne Marie Martin, et al.. (2009). α‐secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Aβ generation. Journal of Neurochemistry. 111(6). 1369–1382. 58 indexed citations
13.
Czirr, Eva, Barbara A. Cottrell, Stefanie Leuchtenberger, et al.. (2008). Independent Generation of Aβ42 and Aβ38 Peptide Species by γ-Secretase. Journal of Biological Chemistry. 283(25). 17049–17054. 64 indexed citations
14.
Leuchtenberger, Stefanie, Juan Manuel Maler, Eva Czirr, et al.. (2008). Nonsteroidal Anti-Inflammatory Drugs and Ectodomain Shedding of the Amyloid Precursor Protein. Neurodegenerative Diseases. 6(1-2). 1–8. 7 indexed citations
15.
Czirr, Eva, Stefanie Leuchtenberger, Cornelia Dorner‐Ciossek, et al.. (2007). Insensitivity to Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs and γ-Secretase Inhibitors Is Common among Aggressive Presenilin-1 Mutations. Journal of Biological Chemistry. 282(34). 24504–24513. 48 indexed citations
16.
Czirr, Eva & Sascha Weggen. (2006). γ-Secretase Modulation with Aβ42-Lowering Nonsteroidal Anti-Inflammatory Drugs and Derived Compounds. Neurodegenerative Diseases. 3(4-5). 298–304. 20 indexed citations
17.
Leuchtenberger, Stefanie, Markus P. Kummer, Thomas Kukar, et al.. (2005). Inhibitors of Rho‐kinase modulate amyloid‐β (Aβ) secretion but lack selectivity for Aβ42. Journal of Neurochemistry. 96(2). 355–365. 26 indexed citations
18.
Mönnich, Maren, et al.. (2004). Outer dense fibre protein 2 (ODF2) is a self-interacting centrosomal protein with affinity for microtubules. Journal of Cell Science. 117(20). 4643–4651. 63 indexed citations
19.
Gao, Shaorong, Eva Czirr, Young Gie Chung, Zhiming Han, & Keith E. Latham. (2004). Genetic Variation in Oocyte Phenotype Revealed Through Parthenogenesis and Cloning: Correlation with Differences in Pronuclear Epigenetic Modification1. Biology of Reproduction. 70(4). 1162–1170. 44 indexed citations
20.
Hoyer‐Fender, Sigrid, Eva Czirr, Rebecca Radde, et al.. (2003). Localisation of histone macroH2A1.2 to the XY-body is not a response to the presence of asynapsed chromosome axes. Journal of Cell Science. 117(2). 189–198. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathaniel S. Woodling Breakdown of academic impact, for papers by Peter Sohn Breakdown of academic impact, for papers by Ilie‐Cosmin Stancu Breakdown of academic impact, for papers by Luka Kulic Breakdown of academic impact, for papers by Michael A. Mastrangelo Breakdown of academic impact, for papers by Kristina Lindholm Breakdown of academic impact, for papers by Stacy A. Hussong Breakdown of academic impact, for papers by Mickaël Audrain Breakdown of academic impact, for papers by Mary Lou Previti Breakdown of academic impact, for papers by Debbie Callaghan
Rankless by CCL
2026